⌘K

Login Start Free

Home/Filings/144/0001957799-24-000252

144//SEC Filing

Janux Therapeutics, Inc. 144

Accession 0001957799-24-000252

CIK 0001873935other

View on SEC.gov Company Profile

Filed

Sep 25, 8:00 PM ET

Accepted

Sep 26, 5:13 PM ET

Size

6.5 KB

Accession

0001957799-24-000252

Documents

1 file

144
primary_doc.xmlPrimary

Issuer

Avalon BioVentures I, LP

CIK 0001873935

Entity typeother

IncorporatedDE

Related Parties

1

filerCIK 0001873935

Filing Metadata

Form type: 144
Filed: Sep 25, 8:00 PM ET
Accepted: Sep 26, 5:13 PM ET
Size: 6.5 KB

View on SEC.gov